Display options
Cite
Xu L, Chen J, Zeng Y, et al. Differential diagnosis of multiple primary lung cancers and intra-lung metastasis of lung cancer by multiple gene detection. Chin Med J (Engl). 2021;135(1):86-88doi: 10.1097/CM9.0000000000001739.
Xu, L., Chen, J., Zeng, Y., Li, X., & Zhang, Z. (2021). Differential diagnosis of multiple primary lung cancers and intra-lung metastasis of lung cancer by multiple gene detection. Chinese medical journal, 135(1), 86-88. https://doi.org/10.1097/CM9.0000000000001739
Xu, Liuyang, et al. "Differential diagnosis of multiple primary lung cancers and intra-lung metastasis of lung cancer by multiple gene detection." Chinese medical journal vol. 135,1 (2021): 86-88. doi: https://doi.org/10.1097/CM9.0000000000001739
Xu L, Chen J, Zeng Y, Li X, Zhang Z. Differential diagnosis of multiple primary lung cancers and intra-lung metastasis of lung cancer by multiple gene detection. Chin Med J (Engl). 2021 Nov 10;135(1):86-88. doi: 10.1097/CM9.0000000000001739. PMID: 34759216.
Copy Download .nbib Format: NLM
Share it on

Chin Med J (Engl). 2021 Nov 10;135(1):86-88. doi: 10.1097/CM9.0000000000001739.

Differential diagnosis of multiple primary lung cancers and intra-lung metastasis of lung cancer by multiple gene detection.

Chinese medical journal

Liuyang Xu, Jin Chen, Yupeng Zeng, Xiao Li, Zhihong Zhang

Affiliations

  1. Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  2. The Fourth Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210029, China.

PMID: 34759216 DOI: 10.1097/CM9.0000000000001739

[No abstract available.]

References

  1. Khaltaev N, Axelrod S. Global lung cancer mortality trends and lifestyle modifications: preliminary analysis. Chin Med J 2020; 133:1526–1532. doi: 10.1097/CM9.0000000000000918. - PubMed
  2. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70:606–612. - PubMed
  3. Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. American College of Physicians. Lung cancer. Special treatment issues. Chest 2003; 123: (1 Suppl): 244S–258S. doi: 10.1378/chest.123.1_suppl.244s. - PubMed
  4. Girard N, Ostrovnaya I, Lau C, Park B, Ladanyi M, Finley D, et al. Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non-Small Cell Lung Cancers. Clin Cancer Res 2009; 15:5184–5190. doi: 10.1158/1078-0432.CCR-09-0594. - PubMed
  5. Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 2011; 12:735–742. doi: 10.1016/S1470-2045(11)70184-X. - PubMed
  6. Sun L, Zhang Q, Luan H, Zhan Z, Wang C, Sun B. Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice. J Exp Clin Cancer Res 2011; 30:30doi: 10.1186/1756-9966-30-30. - PubMed
  7. Sun LN, Zhang Q, Luan HL, Zhan ZL, Sun BC. Comparison of KRAS and EGFR gene statuses between primary non-small cell lung cancer and local lymph node metastases and their clinical significance. Chin J Clin Oncol 2012; 39:970–973. doi: 10.3969/j.issn.l000-8179.2012.14.008. - PubMed

Publication Types